TCG Crossover Fund III
Share
N°01 / About
About TCG Crossover Fund III
Life sciences, biotech, disruptive medicines, innovative therapies. Pre-IPO, crossover, public and private investments (flexible mandate).
N°02 / Thesis
Investment Focus
Location / RegionUnited States
Funding StageGrowth
Industry Focus
Biotech
Therapeutics
Investor Signals Profile
active
Sweet Spot
Biotech therapeutics founder targeting M&A with unmet needs
7 signals on TCG Crossover Fund III
3 bullish · 3 pitch do's · 1 GP profile, each with its source. From €9/month, cancel anytime.